LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the CGMP-PKG Signaling Pathway
Overview
Affiliations
Background: LncRNA EMX2OS (EMX2 opposite strand/antisense RNA) is notably downregulated in prostate cancer (PCa) tissues and may be regarded as a potential molecular biomarker for diagnosis and prognosis. However, its exact role in regulating the development of PCa is obscure.
Methods: The EMX2OS expression was assessed in PCa tissues, paracancer tissues, PCa cells and normal prostate epithelial cells by qPCR. Gain- and loss-of-function experiments were performed to investigate the role of EMX2OS and FUS in cGMP-PKG (cyclic guanosine monophosphate-dependent protein kinase)-mediated proliferation, invasion, and migration in human PCa cell lines DU145 and PC3. Then, the interaction of transcription factor 12 (TCF12) with EMX2OS promoter was confirmed by using the dual-luciferase reporter and chromatin immunoprecipitation (ChIP) assays. RNA binding protein immunoprecipitation and RNA pull-down assays were used to verify the interaction between EMX2OS and FUS protein. Finally, the role of EMX2OS and FUS in tumor growth in vivo was validated in a xenograft nude mouse model.
Results: TCF12 and EMX2OS were both downregulated in PCa tissues and cells, and they negatively regulated cell proliferation, migration and invasion, and activated cGMP-PKG pathway in DU145 and PC3 cells. TCF12 was a transcription factor of EMX2OS. TCF12 and EMX2OS overexpression both down-regulated cell proliferation, migration and invasion, and activated cGMP-PKG pathway in DU145 and PC3 cells. Furthermore, EMX2OS directly bound with FUS protein and had a synergy effect with FUS protein on cGMP-PKG-mediated cell functions, which could be suppressed by (D)-DT-2 (a cGMP-PKG inhibitor). In addition, the overexpression of FUS or EMX2OS individually markedly decreased the volume and weight of tumors in vivo, and co-overexpression of them further inhibited tumor growth.
Conclusion: EMX2OS, transcriptionally regulated by TCF12, played a synergy role with FUS protein in regulating the proliferation, migration and invasion of PCa cells by activating the cGMP-PKG pathway.
Exploring manzamine a: a promising anti-lung cancer agent from marine sponge sp.
Su M, Zhu J, Bai L, Cao Y, Wang S Front Pharmacol. 2025; 16:1525210.
PMID: 40070571 PMC: 11893592. DOI: 10.3389/fphar.2025.1525210.
Sheng L, Lin J, Zhang Y, Chen Y, Ye X, Wang X Commun Biol. 2024; 7(1):1711.
PMID: 39739005 PMC: 11685398. DOI: 10.1038/s42003-024-07428-3.
EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway.
Li X, Liu B, Wang S, Dong Q, Li J Open Med (Wars). 2024; 19(1):20230875.
PMID: 38205153 PMC: 10775416. DOI: 10.1515/med-2023-0875.
Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
Bakkum-Gamez J, Sherman M, Slettedahl S, Mahoney D, Lemens M, Laughlin-Tommaso S Gynecol Oncol. 2023; 174:11-20.
PMID: 37141817 PMC: 10330802. DOI: 10.1016/j.ygyno.2023.04.014.
The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma.
Ma L, Zhang L, Li L, Zhao L Open Med (Wars). 2023; 18(1):20230686.
PMID: 37069939 PMC: 10105521. DOI: 10.1515/med-2023-0686.